Single-cell assays are currently favored to quantitate T-cell responses. Staining antigen-specific T-cells with fluorescently labeled tetrameric major histocompatibility complex (MHC)/peptide complexes has greatly enhanced the ability to assess the cellular dynamics of an immune response at the single-cell level.This article reviews MHC tetramer technology, defining it, discussing how MHC tetramers are made, outlining the benefits of this technology, comparing and contrasting it to other methods for evaluating immune responses, and describing current applications.
Ahmed R
, Gray D. 1996. Immunological memory and protective immunity: understanding their relation. Science272(5258):54-60.
2.
Altman JD
, Moss PA, Goulder PJR, Barouch DH, Mc-Heyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science274:94-96.
3.
Appay V
, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, Spiegel HM, Conlon C, Spina CA, and others. 2000. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med192(1):63-75.
4.
Beltz GT
, Altman JD, Doherty PC. 1998. Characteristics of virusspecific CD8+ T cells in liver during the control and resolution phases of influenza pneumonia. Proc Natl Acad Sci95:13812-13817.
5.
Bonelo A
, Valmori D, Triponez F, Tiercy JM, Mentha G, Oberholzer J, Champagne P, Romero JF, Esposito F, Nebie I, and others. 2000. Generation and characterization of malariaspecific human CD8(+) lymphocyte clones: effect of natural polymorphism on T cell recognition and endogenous cognate antigen presentation by liver cells. Eur J Immunol30(11):3079-3088.
6.
Boon T
, Old LJ. 1997. Cancer tumor antigens. Curr Opin Immunol9:681-683.
7.
Brosterhus H
, Brings S, Leyendeckers H, Manz RA, Miltenyi S, Radbruch A, Assenmacher M, Schmitz JE. 1999. Enrichment and detection of live antigen-specific CD4+ and CD8+ T cells based on cytokine secretion. Eur J Immunol29:4053-4059.
8.
Callan MFC
, Steven N, Drausa P, Mass PAH, Wilson KDK, Bell JI, Rickinson AB, McMichael AJ. 1998a. Large clonal expansions of CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med187:1395-1402.
9.
Callan MFC
, Tan L, Annels N, Ogg GS, Wilson JD, O’Callaghan CA, Steven N, McMichael AJ, Rickinson AB. 1998b. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med187:1395-1402.
10.
Clay TM
, Hobeika AC, Mosca PJ, Lyerly HK, Morse MA. 2001. Assays for monitoring cellular immune responses to active immunotherapy of cancer. Clin Canc Res7(5):1127-1135.
11.
Czerkinsky CC
, Nilsson LA. 1983. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Meth65:109-121.
12.
de St Groth BF
, Smith AL, Koh WP, Girgis L, Cook MC, Bertolino P. 1999. Carboxyfluorescein diacetate succinimidyl ester and the virgin lymphocyte: a marriage made in heaven. Immunol Cell Biol77(6):530-538.
13.
Doherty PC
, Christensen JP. 2000. Accessing complexity: the dynamics of virus-specific T cell responses. Ann Rev Immunol18:561-592.
14.
Doherty PC
, Topham DJ, Tripp RA. 1996. Establishment and persistence of virus-specific CD4+ and CD8+ T cell memory. Immunol Rev150:23-44.
15.
Dudley ME
, Wunderlich J, Nishimura MI, Yu D, Yang JC, Topalian SL, Schwartzentruber DJ, Hwu P, Marincola FM, Sherry R, and others. 2001. Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J Immunother24(4):363-373.
16.
Eren E
, Travers P. 2000. The structure of the major histocompatibility complex and its molecular interactions. In: Lechler R, Warrens A, editors. HLA in health and disease. 2nd ed.San Diego, CA: Academic Press. p 23-33.
17.
Flynn KJ
, Belz GT, Altman JD, Ahmed R, Woodland DL, Doherty PC. 1998. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity8:683-691.
18.
Fong L
, How Y, Rivas A, Benike C, Yuen A, Fisher GA, Davis MM, Engleman EG. 2001. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci98(15):8809-8814.
19.
Gallimore A
, Glithero A, Godkin A, Tissot AC, Pluckthun A, Elliott T, Hengartner H, Zinkernagel RM. 1998. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med187(9):1383-1393.
20.
Gillespie GM
, Wills MR, Appay V, O’Callaghan CA, Murphy M, Smith N, Sissons P, Rowland-Jones S, Bell JI, Moss PA. 2000. Functional heterogeneity and high frequencies of cytomegalovirus-specificCD8+ Tlymphocytes in healthy antibody positive donors. J Virol74:8140-8150.
21.
Goldsby RA
, Kindt TJ, Osborne BA. 2000. Kuby immunology. New York: W. H. Freeman.
22.
Greten TF
, Schneck JP. 2002. Development and use of multimeric major histocompatibility complex molecules. Clin Diag Lab Immunol9(2):216-220.
23.
Greten TF
, Slansky JE, Kubota R, Soldan SS, Jaffee EM, Leist TP, Pardoll DM, Jacobson S, Schneck JP. 1998. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19-specific CD8+ T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci95:7568-7573.
24.
Haanen JBAG
, van Oijen MGCT, Tirion KF, Oomen LCJM, Kruisbeek AM, Vyth-Dreese FA, Schumacher TNM. 2000. In situ detection of virus-and tumor-specific T-cell immunity. Nat Med6(9):1056-1060.
25.
He XS
, Rehermann B, Boisvert J, Mumm J, Maecker HT, Roederer M, Wright TL, Maino VC, Davis MM, Greenberg HB. 2001. Direct functional analysis of epitope-specific CD8+ T cells in peripheral blood. Viral Immunol14(1):59-69.
26.
Helms T
, Boehm BO, Assad RJ, Trezza RT, Lehmann PV, Tary-Lehmann M. 2000. Direct visualization of cytokine-producing, recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients. J Immunol164:3723-3732.
27.
Hesse MD
, Karulin AY, Boehm BO, Lehmann PV. 2001. A T cell clone’s avidity is a function of its activation state. J Immunol167:1353-1361.
28.
Hoffmann TK
, Donnenberg VS, Friebe-Hoffmann U, Meyer EM, Rinaldo CR, DeLeo AB, Whiteside TL, Donnenber AD. 2000. Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex. Cytometry41:321-328.
29.
Hohn H
, Kortsik C, Nilges K, Necker A, Freitag K, Tully G, Neukirch C, Maeurer MJ. 2001. Human leukocyte antigen-A2 restricted and Mycobacterium tuberculosis 19-kDa antigenspecific CD8+ T-cell responses are oligoclonal and exhibit a Tcell cytotoxic type 2 response cytokine-secretion pattern. Immunology104(3):278-288.
30.
Janeway CAJ
, Travers P, Walport M, Capra JD. 1999. Immunobiology: the immune system in health and disease. London: Current Biology Publications.
31.
Jeffery KJ
, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, and others. 1999. HLA alleles determine human T-lymphotropic virus-I (HTLVI) proviral load and the risk of HTLV-I associated myelopathy. Proc Natl Acad Sci96:3848-3853.
32.
Karulin AY
, Hesse MD, Tary-Lehmann M, Lehmann PV. 2000. Single-cytokine-producing CD4 memory cells prevail in vivo, in type 1/type 2 immunity. J Immunol164:1862-1872.
33.
Klenerman P
, Cerundolo V, Dunbar PR. 2002. Tracking T cells with tetramers: new tales from new tools. Nat Rev Immunol2:263-272.
34.
Kuon W
, Holzhutter HG, Appel H, Grolms M, Kollnberger S, Traeder A, Henklein P, Weiss E, Thiel A, Lauster R, and others. 2001. Identification of HLA-B27-restricted peptides from the Chlamydia trachomatis proteome with possible relevance to HLA-B27-associated diseases. J Immunol167(8):4738-4746.
35.
Kuroda MJ
, Schmitz J, E., Barouch DH, Craiu A, Allen TM, Sette A, Watkins DI, Forman MA, Letvin NL. 1998. Analysis of gagspecific cytotoxic T lymphocytes in SIV mac-infected rhesus monkeys by cell staining with tetrameric MHC class I-peptide complex. J Exp Med187:1373-1381.
36.
Kwok WW
, Gebe JA, Liu AW, Agar S, Ptacek N, Hammer J, Koelle DM, Nepom GT. 2001. Rapid epitope identification from complex class-II-restricted T-cell antigens. Trends Immunol22(11):583-588.
37.
Lebowitz MS
, O’Herrin SM, Hamad AR, Fahmy T, Marguet D, Barnes NC, Pardoll D, Bieler JG, Schneck JP. 1999. Soluble, high-affinity dimers of T-cell receptors and class II major histocompatibility complexes: biochemical probes for analysis and modulation of immune responses. Cell Immunol192(2):175-184.
38.
Lyons AB
. 1999. Divided we stand: tracking cell proliferation with carboxyfluorescein diacetate succinimidyl ester. Immunol Cell Biol77(6):509-515.
39.
Maino VC
, Picker LJ. 1998. Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry34:207-215.
40.
Manz R
, Assenmacher M, Pfluger E, Miltenyi S, Radbruch A. 1995. Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix. Proc Natl Acad Sci92(6):1921-1925.
41.
Marsh SGE
, Parham P, Barber LD. 2000. The HLA facts book. San Diego, CA: Academic Press.
42.
Matzinger P
. 1991. The JAM test: a simple assay for DNA fragmentation and cell death. J Immunol Meth145(1-2):185-192.
43.
McMichael AJ
, O’Callaghan CA. 1998. A new look at T cells. J Exp Med187(9):1367-1371.
44.
Murali-Krishna K
, Altman JD, Suresh M, Sourdive D, Zajac A, Ahmed R, editors. 1998a. In vivo dynamics of anti-viral CD8 T cell responses to different epitopes: an evaluation of bystander activation in primary and secondary responses to viral infection. New York: Plenum.
45.
Murali-Krishna K
, Altman JD, Suresh M, Sourdive DJD, Zajac AJ, Miller JD, Stansky J, Ahmed R. 1998b. Counting antigenspecific CD8+ T cells: a reevaluation of bystander activation during viral infection. Immunity8:177-187.
46.
National Institute of Allergy and Infectious Diseases Tetramer Core Facility
. 2001. Facility guide overview. Bethesda, MD: National Institute of Allergy and Infectious Diseases.
47.
Novak EJ
, Liu AW, Gebe JA, Falk BA, Nepom GT, Koelle DM, Kwok WW. 2001. Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens. J Immunol166:6665-6670.
48.
Novak EJ
, Liu AW, Nepom GT, Kwok WW. 1999. MHC class II tetramers identify peptide-specific human CD4+ T cells proliferating in response to influenza A antigen. J Clin Inves104(12):R63-R67.
49.
Oelke M
, Kurokawa T, Hentrich I, Behringer D, Cerundolo V, Lindemann A, Machensen A. 2000. Functional characterization of CD8+ antigen-specific cytotoxic T lymphocytes after enrichment based on cytokine secretion: comparison with the MHC-tetramer technology. Scand J Immunol52(6):544-549.
50.
Ogg GS
, Jin X, Bonhoeffer S, Moss P, Nowak MA, Monard S, Segal JP, Cao Y, Rolwland-Jones SL, Hurley A, and others. 1999. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol73:797-800.
51.
Paul W
. 1998. Fundamental immunology. Baltimore, MD: Lippincott, Williams and Wilkins.
52.
Pedersen LO
, Nissen MG, Hansen NJV, Nielsen LL, Lauenmoller SL, Blicher T, Nansen A, Sylvester-Hvid C, Randrup AR, Buus S. 2001. Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bonds. Eur J Immunol31:2986-2996.
53.
Pittet MJ
, Speiser DE, Lienard D, Valmori D, Guillaume P, Dutoit V, Rimoldi KD, Lejeune F, Cerottinit JC, Romero P. 2001. Expansion and functional maturation of human tumor antigenspecific CD8+ T cells after vaccination with antigenic peptide. Clin Canc Res7(Suppl 3):796S-803S.
54.
Prussin C
, Metcalfe D. 1995. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anticytokine antibodies. J Immunol Meth188:117-128.
55.
Rosenberg SA
. 2001. Progress in human tumour immunology and immunotherapy. Nature411(6835):380-384.
56.
Rothenberg EV
. 1996. How Tcells count. Science273(5271):78-79.
57.
Schneck JP
. 2000. Monitoring antigen-specific T cells using MHC-Ig dimers. Immunol Invest29(2):163-169.
58.
Sedgwick JD
, Holt PG. 1983. A solid phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J Immunol Meth57:301-309.
59.
Selin LK
, Lin MY, Kraemer KA, Pardoll DM, Schneck JP, Varga SM, Santolucito PA, Pinto AK, Welsh KI. 1999. Attrition of T cell memory: selective loss of LCMV epitope-specific emory CD8 T cells following infections with heterologous viruses. Immunity11(6):733-742.
60.
Sherritt M
, Cooper L, Moss DJ, Kenzle N, Altman JD, Khanna KR. 2001. Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters. Int Immunol13(3):265-271.
61.
Skinner PJ
, Daniels MA, Schmidt CS, Jameson SC, Haase AT. 2000. Cutting edge: in situ tetramer staining of antigen-specific T cells in tissues. J Immunol165:613-615.
62.
Valitutti S
, Muller S, Dessing M, Lanzavecchia A. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J Exp Med183:1917-1921.
63.
Valmori D
, Dutoit V, Lienard D, Lejeune F, Speiser D, Rimoldi KD, Cerundolo V, Dietrich PY, Cerottinit JC, Romero P. 2000. Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specificCD8+ Tcells in melanoma patients. J Immunol165(1):533-538.
64.
Wilson CS
, Moser JM, Altman JD, Jensen PE, Lukacher AE. 1999. Cross-recognition of two middle T protein epitopes by immunodominant polyoma virus-specific CTL. J Immunol162(7):3933-3941.
65.
Wodarz D
, Nowak MA, Bangham CR. 1999. The dynamics of HTLV-I and the CTL response. Immunol Today20:220-227.
